Adam Bruce, CEO & Chair of Abarceo Pharma, presents at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to...
BioStock’s Natasha Bank interviews Adam Bruce, CEO & Chair of Abarceo Pharma, at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life...
Today ABARCEO PHARMA is celebrating the birthday of Sir Frederick Banting, who discovered insulin. It is also the World Diabetes Day, this year with the theme, “Breaking Barries, Bridging Gaps”Truly the spirit that we at Abarceo live and work by in the...
November 4–6 were spent at BIO-Europe® in Stockholm. It is an amazing event, bringing together not only the European but the global, this time 5500 strong, Biotech BD family. “I am grateful to the organizers for a great event making the 30th anniversary truly...
Abarceo Pharma får Almi Invest som ny delägare när de nu tar in total 21,5 miljoner kroner. Pengarna ska räcka i ett år och bland annat användas för att bestämma vilken läkemedelskandidat som de ska utveckla vidare. Bolaget har i nuläget flera möjliga kandidater för...
Almi Invest investerar 7,5 miljoner kronor i Abarceo Pharma, som utvecklar ett nytt läkemedel mot diabetes typ 2. I emissionen på totalt 21,5 miljoner kronor deltar även privata investerare. Pengarna ska användas till att nå viktiga milstolpar såsom att välja...
Recent Comments